Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • News

AstraZeneca’s Tagrisso-Chemo Combo Under FDA Priority Review For Most Common Form Of Lung Cancer

By Vandana Singh
October 16, 10:20 AM
AstraZeneca Plc's (NASDAQ: AZN) supplemental New Drug Application for Tagrisso (osimertinib) in combination with chemotherapy has been accepted and 

AZN

Read More
2 minute read
  • Earnings
  • Equities
  • Large Cap
  • Markets
  • News

Charles Schwab Posts Mixed Q3 Earnings: Net Interest Revenue Dips Amid Higher Interest Rate Environment

By Lekha Gupta
October 16, 9:10 AM
Charles Schwab Corp (NYSE: SCHW) reported a Q3 net revenue decline of 16% Y/Y to $4.61 billion, 

SCHW

Read More
2 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News

Pfizer Cuts Annual Revenue Guidance By $9B Amid COVID-19 Vaccine Sales Slump, BioNTech Warns €900M Write-Offs

By Vandana Singh
October 16, 7:58 AM
Friday, Pfizer Inc (NYSE: PFE) slashed its full-year earnings and revenue guidance, citing decreasing demand for its 

BNTX

Read More
2 minute read
  • Equities
  • Large Cap
  • Markets
  • News

Honeywell Projects New Business Jet Deliveries To Shoot Up 10% In 2024: Here’s Details

By Lekha Gupta
October 16, 7:32 AM
Yesterday, Honeywell International Inc (NASDAQ: HON) disclosed an encouraging Global Business Aviation Outlook, highlighting 

HON

Read More
2 minute read
  • Equities
  • Financing
  • Large Cap
  • M&A
  • Markets
  • News

KKR & Flerie Form New Platform To Drive Specialized Pharma Services, Invest In Munich-Based Coriolis Pharma

By Lekha Gupta
October 16, 6:23 AM
KKR & Co Inc (NYSE: KKR), in collaboration with Flerie, disclosed the formation of a new 

KKR

Read More
1 minute read
  • Equities
  • Large Cap
  • M&A
  • Markets
  • News
  • Penny Stocks

Amphenol To Buy PCTEL At 50% Premium: Here’s Details

By Lekha Gupta
October 16, 6:01 AM
On Friday, Amphenol Corp (NYSE: APH) inked a deal to acquire PCTEL Inc (NASDAQ: PCTI) 

APH

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • News
  • Top Stories

FDA OKs Pfizer’s New Bowel Disease Drug, Analysts Predict Peak Sales Of $3B A Year

By Vandana Singh
October 13, 12:26 PM
The Food and Drug Administration (FDA) approved Pfizer Inc's (NYSE: PFE) Velsipity (etrasimod), an oral, once-daily, selective sphingosine-1-phosphate (S1P) receptor modulator for adults with moderately to severely active 

BMY

Read More
1 minute read
  • Dividends
  • Earnings
  • Equities
  • Guidance
  • Large Cap
  • Markets
  • Movers
  • News

Why PNC Financial Services Shares Are Falling Today

By Lekha Gupta
October 13, 11:57 AM
PNC Financial Services Group Inc (NYSE: PNC) shares are trading lower after the company 

PNC

Read More
3 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Large Cap
  • Top Stories

Q3 Earnings Season Starts Strong For Banks As High Interest Rates Fuel Profits Bonanza

By Piero Cingari
October 13, 11:22 AM
U.S. financial institutions kicked off earnings season on a robust note, surpassing analysts' expectations for third-quarter earnings per share.

BLK

Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News
  • Top Stories

Ozempic Weight Loss Drug Maker Is Making Money Hand Over Fist – And Just Raised Its Profit Forecast

By Vandana Singh
October 13, 10:31 AM
Novo Nordisk A/S (NYSE: NVO) raised its FY23 guidance as sales of its block

NVO

Posts pagination

Previous 1 … 191 192 193 … 437 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service